Citation Impact
Citing Papers
Fibroblast Growth Factor 19 Increases Metabolic Rate and Reverses Dietary and Leptin-Deficient Diabetes
2004
CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment
2014
Obesity and Metabolic Syndrome in Circadian Clock Mutant Mice
2005 StandoutScience
Targeting bile-acid signalling for metabolic diseases
2008
Tissue-specific Expression of βKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21
2007
Downregulation of Plk1 Expression By Receptor-Mediated Uptake of Antisense Oligonucleotide-Loaded Nanoparticles
2008
Circadian Transcription
2002
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
2009 StandoutNature
Co-receptor Requirements for Fibroblast Growth Factor-19 Signaling
2007
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
2014 Standout
PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rules
1993 StandoutNature
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
2005 Standout
Effect of RNA Silencing of Polo-Like Kinase-1 (PLK1) on Apoptosis and Spindle Formation in Human Cancer Cells
2002
The FGF family: biology, pathophysiology and therapy
2009 Standout
Cell death by mitotic catastrophe: a molecular definition
2004
Structural basis for fibroblast growth factor receptor activation
2005
Crystal structure of parallel quadruplexes from human telomeric DNA
2002 StandoutNature
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Cell-cycle checkpoints and cancer
2004 StandoutNature
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
2006 StandoutNature
Chk1 and Chk2 kinases in checkpoint control and cancer
2003
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
2014 StandoutNature
αv Integrins as receptors for tumor targeting by circulating ligands
1997
Telomere maintenance mechanisms as a target for drug development
2000
Correction: CDK4/ 6 inhibition provides a potent adjunct to Her2- targeted therapies in preclinical breast cancer models
2021
Targeting cell cycle and hormone receptor pathways in cancer
2013
Mismatch repair and nucleotide excision repair proteins cooperate in the recognition of DNA interstrand crosslinks
2009 StandoutNobel
Pathways of apoptotic and non-apoptotic death in tumour cells
2004
Biological Activity and Biotechnological Aspects of Peptide Nucleic Acid
2006
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
2005
Bile acid sequestrants
2011
Regulation of Complement C3 Expression by the Bile Acid Receptor FXR
2004
Analyzing real-time PCR data by the comparative CT method
2008 Standout
Independent Repression of Bile Acid Synthesis and Activation of c-Jun N-terminal Kinase (JNK) by Activated Hepatocyte Fibroblast Growth Factor Receptor 4 (FGFR4) and Bile Acids
2005
The Chk2 protein kinase
2004
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies
2007
Structure and Activation Mechanism of the CHK2 DNA Damage Checkpoint Kinase
2009
Control of apoptosis and mitotic spindle checkpoint by survivin
1998 StandoutNature
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
Functional interactions between the gut microbiota and host metabolism
2012 StandoutNature
Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression
2001 StandoutNobel
Impaired negative feedback suppression of bile acid synthesis in mice lacking βKlotho
2005
PU.1 and Interferon Consensus Sequence-binding Protein Regulate the Myeloid Expression of the Human Toll-like Receptor 4 Gene
2000 StandoutNobel
A polymeric form of fibronectin has antimetastatic effects against multiple tumor types
1996
Neuroligin 1: A splice site-specific ligand for β-neurexins
1995 StandoutNobel
Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models
2007
Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities
2003
Phase transitions in the assembly of multivalent signalling proteins
2012 StandoutNature
DNA triple helices: Biological consequences and therapeutic potential
2008
Computational redesign of endonuclease DNA binding and cleavage specificity
2006 StandoutNatureNobel
Cyclin-dependent kinase inhibitor therapy for hematologic malignancies
2013
Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism
2006
Klotho converts canonical FGF receptor into a specific receptor for FGF23
2006 StandoutNature
Bile acids as regulatory molecules
2009
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
2005 StandoutNature
Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis
2009
Collaboration of Brca1 and Chk2 in tumorigenesis
2004
Structural Characterization of PNA-DNA Duplexes by NMR. Evidence for DNA in a B-like Conformation
1994
Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man
2006
Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms
2003
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Targeting the checkpoint kinases: chemosensitization versus chemoprotection
2004
Cell Cycle-dependent Regulation of the Cyclin B1 Promoter
1995
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
The molecular basis of ATM-dependent dimerization of the Mdc1 DNA damage checkpoint mediator
2012 StandoutNobel
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Regulation of hepatic metabolic pathways by the orphan nuclear receptor SHP
2005
Cellular senescence: from physiology to pathology
2014 Standout
Trex1 Exonuclease Degrades ssDNA to Prevent Chronic Checkpoint Activation and Autoimmune Disease
2007 StandoutNobel
Regulating gene expression with light-activated oligonucleotides
2006
Clues from cell metabolism
2010 StandoutNatureNobel
Deoxynucleic Guanidine/Peptide Nucleic Acid Chimeras: Synthesis, Binding and Invasion Studies with DNA
2000
Molecular Pathways: CDK4 Inhibitors for Cancer Therapy
2014
Peptide nucleic acid-targeted mutagenesis of a chromosomal gene in mouse cells
1998
Peptide Nucleic Acid. A Molecule with Two Identities
1999
Trastuzumab in the management of early and advanced stage breast cancer.
2007
Supramolecular Double-Helix Formation by Diastereoisomeric Conformations of Configurationally Enantiomeric Macrocycles
2016 StandoutNobel
Molecular Dynamics Simulations of PNA·DNA and PNA·RNA Duplexes in Aqueous Solution
2000
Nonionic Analogs of RNA with Dimethylene Sulfone Bridges
1996
Cancer Cell Cycles
1996 StandoutScience
Chiroptical Molecular Switches
2000 StandoutNobel
The new frontier of genome engineering with CRISPR-Cas9
2014 StandoutScienceNobel
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero
1998 StandoutNobel
CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models
2014
The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosis until the onset of S phase.
1996 StandoutNobel
Folding of Oligoviologens Induced by Radical–Radical Interactions
2014 StandoutNobel
Double duplex invasion by peptide nucleic acid: A general principle for sequence-specific targeting of double-stranded DNA
1999
Kinetics and mechanism of polyamide ("peptide") nucleic acid binding to duplex DNA.
1995
Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome
2004 StandoutNobel
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
pVHL 19 is a biologically active product of the von Hippel–Lindau gene arising from internal translation initiation
1998 StandoutNobel
Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides.
1993
Reversible Photocontrol of Biological Systems by the Incorporation of Molecular Photoswitches
2013 StandoutNobel
A Field Guide to Foldamers
2001 Standout
NMR Solution Structure of a Peptide Nucleic Acid Complexed with RNA
1994 Science
Ionic Effects on the Stability and Conformation of Peptide Nucleic Acid Complexes
1996
PU.1/Pip and Basic Helix Loop Helix Zipper Transcription Factors Interact With Binding Sites in the CD20 Promoter to Help Confer Lineage- and Stage-Specific Expression of CD20 in B Lymphocytes
1997
Reversible Optical Transcription of Supramolecular Chirality into Molecular Chirality
2004 StandoutScienceNobel
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Enzymatic synthesis of DNA on glycerol nucleic acid templates without stable duplex formation between product and template
2007 StandoutNobel
PD-loop: A complex of duplex DNA with an oligonucleotide
1998
Requirement of p27 Kip1 for Restriction Point Control of the Fibroblast Cell Cycle
1996 Science
Targeting CDK4 and CDK6: From Discovery to Therapy
2015
βKlotho Is Required for Fibroblast Growth Factor (FGF) 21 Signaling through FGF Receptor (FGFR) 1c and FGFR3c
2008
Suppression of the Malignant Phenotype of Melanoma Cells by Anti-Oncogene Ribozymes
1996
CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer
2014
Peptide Nucleic Acids with a Conformationally Constrained Chiral Cyclohexyl‐Derived Backbone
1997
THE UBIQUITIN SYSTEM
1998 StandoutNobel
Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles
2004 StandoutNobel
MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition
2015
Liquid phase condensation in cell physiology and disease
2017 StandoutScience
A Nucleic Acid Triple Helix Formed by a Peptide Nucleic Acid-DNA Complex
1995 Science
A synthetic peptide derived from the carboxy terminus of the laminin A chain represents a binding site for the alpha 3 beta 1 integrin
1992
Works of John Bisi being referenced
Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
2006
Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy
2012
Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line
1991
An assessment of the antisense properties of RNase H-competent and steric-blocking oligomers
1995
PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2
2002
Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis
2003
Impact of biophysical parameters on the biological assessment of peptide nucleic acids, antisense inhibitors of gene expression
1995
Evaluation of targeted bone marrow arrest by G1T28, a CDK4/6 inhibitor in clinical development to reduce chemotherapy-induced myelosuppression.
2015
Antisense and Antigene Properties of Peptide Nucleic Acids
1992 Science
Dominant-negative polo-like kinase 1 induces mitotic catastrophe independent of cdc25C function.
2000
Upstream Stimulatory Factor Regulates Expression of the Cell Cycle-Dependent Cyclin B1 Gene Promoter
1995
Strand-invasion of duplex DNA by peptide nucleic acid oligomers.
1993
CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury
2013